IL140603A0 - Agents with an antidepressive effect - Google Patents

Agents with an antidepressive effect

Info

Publication number
IL140603A0
IL140603A0 IL14060399A IL14060399A IL140603A0 IL 140603 A0 IL140603 A0 IL 140603A0 IL 14060399 A IL14060399 A IL 14060399A IL 14060399 A IL14060399 A IL 14060399A IL 140603 A0 IL140603 A0 IL 140603A0
Authority
IL
Israel
Prior art keywords
agents
antidepressive effect
antidepressive
effect
Prior art date
Application number
IL14060399A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of IL140603A0 publication Critical patent/IL140603A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14060399A 1998-07-07 1999-07-02 Agents with an antidepressive effect IL140603A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830201A DE19830201A1 (de) 1998-07-07 1998-07-07 Mittel mit antidepressiver Wirkung
PCT/EP1999/004595 WO2000002542A2 (de) 1998-07-07 1999-07-02 Mittel mit antidepressiver wirkung, enthaltend pramipexol und ein weiteres antidepressivum

Publications (1)

Publication Number Publication Date
IL140603A0 true IL140603A0 (en) 2002-02-10

Family

ID=7873155

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14060399A IL140603A0 (en) 1998-07-07 1999-07-02 Agents with an antidepressive effect

Country Status (33)

Country Link
US (1) US6255329B1 (cs)
EP (1) EP1093369B1 (cs)
JP (1) JP2002520273A (cs)
KR (1) KR100557692B1 (cs)
CN (1) CN1230168C (cs)
AR (1) AR019896A1 (cs)
AT (1) ATE228365T1 (cs)
AU (1) AU762128B2 (cs)
BG (1) BG64972B1 (cs)
BR (1) BR9911768A (cs)
CA (1) CA2336833C (cs)
CZ (1) CZ294087B6 (cs)
DE (2) DE19830201A1 (cs)
DK (1) DK1093369T3 (cs)
EA (1) EA003142B1 (cs)
EE (1) EE04296B1 (cs)
ES (1) ES2183583T3 (cs)
HK (1) HK1037976A1 (cs)
HU (1) HUP0103922A3 (cs)
ID (1) ID27776A (cs)
IL (1) IL140603A0 (cs)
MY (1) MY117969A (cs)
NO (1) NO20010064L (cs)
NZ (1) NZ509729A (cs)
PL (1) PL195043B1 (cs)
PT (1) PT1093369E (cs)
RS (1) RS49795B (cs)
SK (1) SK284923B6 (cs)
TR (1) TR200100146T2 (cs)
TW (1) TW592698B (cs)
WO (1) WO2000002542A2 (cs)
YU (1) YU401A (cs)
ZA (1) ZA200100090B (cs)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006162A1 (de) * 1998-07-27 2000-02-10 Boehringer Ingelheim Pharma Kg Mittel mit antidepressiver wirkung, mit pramipexol und einem weiteren antidepressivum
WO2002069974A1 (en) * 2001-03-05 2002-09-12 Andrew Holman Administration of sleep restorative agents
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
US20060281797A1 (en) * 2001-12-11 2006-12-14 University Of Virginia Patent Foundation Neurorestoration with R(+) Pramipexole
IL162408A0 (en) * 2001-12-11 2005-11-20 Univ Virginia Use of pramipexole to treat amyotrophic lateral scelrosis
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
CA2554616A1 (en) * 2004-01-22 2005-08-04 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
CA2619217A1 (en) * 2005-08-15 2007-02-22 University Of Virginia Patent Foundation Neurorestoration with r(+) pramipexole
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
WO2007137071A2 (en) 2006-05-16 2007-11-29 Knopp Neurosciences, Inc. Compositions of r(+) and s(-) pramipexole and methods of using the same
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
AU2008224844B2 (en) 2007-03-14 2012-08-09 Knopp Neurosciences, Inc. Synthesis of chirally purified substituted benzothiazole diamines
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
CA2734491A1 (en) 2008-08-19 2010-02-25 Knopp Neurosciences, Inc. Compositions and methods of using (r)-pramipexole
WO2010028207A2 (en) 2008-09-05 2010-03-11 Supernus Pharmaceuticals, Inc. Method of treatment of attention deficit/hyperactivity disorder (adhd)
AU2010242971A1 (en) * 2009-04-30 2011-11-24 Supernus Pharmaceuticals, Inc. Method of treatment of depression
WO2013096816A1 (en) 2011-12-22 2013-06-27 Biogen Idec Ma Inc. Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
JP6290100B2 (ja) 2012-02-08 2018-03-07 スパーナス ファーマシューティカルズ インコーポレイテッド ビロキサジンの緩和放出製剤
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
DK3019167T3 (da) 2013-07-12 2021-03-15 Knopp Biosciences Llc Behandling af forhøjede niveauer af eosinophiler og/eller basophiler
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
EP3033081B1 (en) 2013-08-13 2021-05-12 Knopp Biosciences LLC Compositions and methods for treating chronic urticaria
WO2015023786A1 (en) 2013-08-13 2015-02-19 Knopp Biosciences Llc Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
EP3609495A4 (en) * 2017-04-10 2020-12-02 Chase Therapeutics Corporation NK1 ANTAGONIST COMBINATION AND METHOD OF TREATMENT OF SYNUCLEINOPATHIA
JP7158425B2 (ja) 2017-06-30 2022-10-21 チェイス セラピューティクス コーポレイション Ｎｋ－１アンタゴニスト組成物およびうつ病の処置における使用法
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
DE3572485D1 (en) * 1984-12-22 1989-09-28 Thomae Gmbh Dr K Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
JP3947582B2 (ja) * 1995-08-15 2007-07-25 中外製薬株式会社 不安神経症治療剤
KR100305071B1 (ko) * 1996-03-29 2001-12-12 디. 제이. 우드, 스피겔 알렌 제이 벤질-락탐유도체및/또는벤질리덴-락탐유도체,이들의제조방법및이들의세로토닌1에이및/또는세로토닌1디수용체의선택적인길항제및/또는작용제로서의용도
ATE282417T1 (de) * 1996-12-02 2004-12-15 Merck Sharp & Dohme Die verwendung von nk-1 rezeptor antagonisten für die behandlung von bewegungsstörungen
CN1293573A (zh) * 1998-01-13 2001-05-02 同步神经元有限责任公司 迟发性运动障碍和其它运动疾病的治疗方法

Also Published As

Publication number Publication date
RS49795B (sr) 2008-06-05
EE04296B1 (et) 2004-06-15
CN1230168C (zh) 2005-12-07
MY117969A (en) 2004-08-30
TR200100146T2 (tr) 2001-07-23
US6255329B1 (en) 2001-07-03
BR9911768A (pt) 2001-04-03
WO2000002542A2 (de) 2000-01-20
KR100557692B1 (ko) 2006-03-07
DE19830201A1 (de) 2000-01-13
EE200100014A (et) 2002-06-17
PL345842A1 (en) 2002-01-14
EA200100084A1 (ru) 2001-08-27
NO20010064D0 (no) 2001-01-05
ES2183583T3 (es) 2003-03-16
CA2336833A1 (en) 2000-01-20
BG105112A (en) 2001-10-31
CA2336833C (en) 2008-09-23
AU762128B2 (en) 2003-06-19
PT1093369E (pt) 2003-03-31
EA003142B1 (ru) 2003-02-27
HK1037976A1 (en) 2002-03-01
PL195043B1 (pl) 2007-08-31
CN1308533A (zh) 2001-08-15
CZ200177A3 (en) 2001-06-13
SK112001A3 (en) 2001-10-08
AR019896A1 (es) 2002-03-20
TW592698B (en) 2004-06-21
YU401A (sh) 2003-10-31
JP2002520273A (ja) 2002-07-09
EP1093369A2 (de) 2001-04-25
ZA200100090B (en) 2002-04-04
ID27776A (id) 2001-04-26
CZ294087B6 (cs) 2004-10-13
SK284923B6 (sk) 2006-02-02
WO2000002542A3 (de) 2000-06-22
NZ509729A (en) 2003-06-30
DE59903556D1 (de) 2003-01-09
HUP0103922A3 (en) 2002-08-28
ATE228365T1 (de) 2002-12-15
AU5030399A (en) 2000-02-01
EP1093369B1 (de) 2002-11-27
DK1093369T3 (da) 2002-12-16
NO20010064L (no) 2001-03-02
HUP0103922A2 (hu) 2002-03-28
BG64972B1 (bg) 2006-11-30
KR20010079491A (ko) 2001-08-22

Similar Documents

Publication Publication Date Title
IL140603A0 (en) Agents with an antidepressive effect
PL343923A1 (en) New use
AU138171S (en) Goggles
EP1103829A4 (en) POLARIZER
GB9818914D0 (en) Use
GB9814640D0 (en) New use
PL332616A1 (en) Hydoxymethylhexanones as odorising and savourising agents
GB2337549B (en) Retaining components
HUP0105165A3 (en) Lichting arrangement
GB9808496D0 (en) Resistance-monitoring arrangement
GB9828004D0 (en) Use
GB9807503D0 (en) Use
GB9817064D0 (en) New use
GB2335259B (en) An explosion-suppressing structure
GB2339003B (en) Movement-damping arrangements
GB9826348D0 (en) Advance arrangement
GB9817911D0 (en) New use
GB2337526B (en) Easy rockeries
PL324932A1 (en) Mould-killing agent
TW348390U (en) Auto-bating device with multi-hooks
CA83191S (en) Dickie
GB9808779D0 (en) Concept one
GB9828003D0 (en) Use
GB9805590D0 (en) Use
GB9805593D0 (en) Earpieces

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees